
Blood is often collected during routine clinical procedures and over the course of research projects, such as clinical trials or longitudinal studies. Clinicians and researchers can access a wealth of information from blood, including insights into disease progression and drug efficacies and toxicities. But, due to rapid degradation of biomolecules, such as RNA, insights are often limited to analyses that can be conducted within 24 hours of collection.
We developed a protocol for direct fixation and storage of whole blood that preserves RNA integrity and single cell information to overcome this limitation and enable reliable, sensitive scRNA-seq of these tricky samples with the Chromium Single Cell Gene Expression Flex assay.
Explore the resources below to learn how this unique Flex workflow can help you examine the cell populations driving biological phenomena at every stage of the drug discovery and development pipeline.

10x researchers presented the results of scRNA-seq analyses of fixed whole blood samples derived from multiple myeloma (MM) patients with and without CAR T-cell therapy at the 2024 AACR Annual Meeting. They demonstrated that:

This webinar walks through key steps in our blood fixation protocol and discusses the potential insights downstream scRNA-seq analysis can provide. Watch it to get the details, including:

This protocol outlines fixation of blood and isolation of peripheral blood mononuclear cells (PBMCs) and leukocytes from whole fixed blood for use with the Chromium Gene Expression Flex workflow. Find all the information you need to get started on your next experiment.